AZD2265 (FPI-2265) clinical trials

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

This study is looking at new ways to treat advanced prostate cancer that has spread. Researchers are testing different medicines to see how safe they are, if they have side effects, and how well they work in men whose cancer hasn't responded to previous treatments.